Skip to main content
. 2015 Dec 30;234(3):328–335. doi: 10.1016/j.pscychresns.2015.10.007

Table 1.

Demographics, clinical characteristics and task performance of study groups.

Healthy participants Patients
Preserved insight group Poor insight group
n=16; (13M:3F) n=13; (11M:2F) n=13; (9M:4F)
Demographics Mean (SD) Range Mean (SD) Range Mean (SD) Range

Age (years) 31.81 (9.36) 20–59 31.15 (9.77) 19–52 37.85 (7.43) 26–49
Education (years) 15.81 (2.76) 11–20 13.38 (2.93) 9–20 13.54 (2.30) 11–19
Predicted IQ (NART)a 115.67 (8.65) 95–128 110.04 (10.50) 86–122 106.92 (9.66) 90–124
Clinical characteristics
bBIS insight score 13.61 (0.62) 13–14 5.97 (1.69) 2–8
Age at illness onset (years) 21.23 (7.06) 12–38 22.69 (5.68) 10–31
Duration of illness (years) 9.92 (7.22) 1–30 15.15 (9.64) 1–24
cPositive symptoms 18.15 (5.10) 10–25 16.23 (4.44) 8–22
cNegative symptoms 18.31 (5.12) 7–27 17.85 (6.84) 8–27
cGeneral psychopathology 35.46 (7.95) 26–56 30.62 (6.96) 21–40
cTotal symptoms 71.92 (15.87) 44–108 64.69 (16.11) 37–86
Antipsychotic dose (chlorpromazine equivalent in mg) 467.08 (400.46) 160–1600 623.80 (392.59) 200–1367
Antipsychotic type 10 patients on atypical, 1 on typical and 2 on both types 7 patients on atypical, 4 on typical and 2 on both types
*Performance
Percentage correct
RT (s)
Percentage correct
RT (s)
Percentage correct
RT (s)
Mean (SD)
Mean (SD)
Mean (SD)
Mean (SD)
Mean (SD)
Mean (SD)

Self 92.58 (6.54) 1.66 (0.36) 91.83 (5.34) 2.30 (0.66) 80.29 (19.74) 2.62 (0.88)
Self-distorted 78.13 (27.58) 2.00 (0.34) 57.69 (35.28) 2.65 (0.55) 63.94 (31.99) 2.55 (0.68)
Other 85.15 (19.62) 1.96 (0.52) 72.60 (21.12) 2.60 (0.38) 67.31 (25.66) 2.64 (0.69)
Other-distorted 56.64 (26.95) 2.27 (0.68) 61.54 (31.23) 2.88 (0.66) 51.44 (28.32) 3.02 (0.82)
Total 78.13 (2.41) 1.97 (0.42) 70.91 (2.22) 2.61 (0.48) 65.75 (4.78) 2.71 (0.73)

RT= Reaction time for correct responses.

a

National Adult Reading Test.

b

Birchwood insight scale (BIS).

c

PANSS: Positive and Negative Symptom Scale.